The present status of screening and diagnosis of early lung cancer

D. E. Williams, Denis Cortese

Research output: Contribution to journalArticle

Abstract

The 'bottom line' regarding any benefit from detection and treatment of early lung cancer will be a difference in mortality in the screened versus control groups. This has not yet been shown in the preliminary results of the cooperative studies - nor could we really expect it. If screening is indeed saving the lives of patients with early stage lung cancer, it should take some years of careful follow-up for that fact to become apparent, much less achieve statistical significance. We conclude that: roentgenographic and cytologic screening can detect cases at an earlier stage of the disease; those patients surgically resected in stage I (AJC) experience better survival, screening has not yet been shown to reduce mortality from lung cancer, but further judgment of its effectiveness awaits completion of three major studies reviewed in this report.

Original languageEnglish (US)
Pages (from-to)210-217
Number of pages8
JournalSeminars in Respiratory Medicine
Volume3
Issue number3
StatePublished - 1982
Externally publishedYes

Fingerprint

Lung Neoplasms
Mortality
Control Groups
Survival
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The present status of screening and diagnosis of early lung cancer. / Williams, D. E.; Cortese, Denis.

In: Seminars in Respiratory Medicine, Vol. 3, No. 3, 1982, p. 210-217.

Research output: Contribution to journalArticle

@article{82c99eeedc8f4958b0278887d0cf1f9f,
title = "The present status of screening and diagnosis of early lung cancer",
abstract = "The 'bottom line' regarding any benefit from detection and treatment of early lung cancer will be a difference in mortality in the screened versus control groups. This has not yet been shown in the preliminary results of the cooperative studies - nor could we really expect it. If screening is indeed saving the lives of patients with early stage lung cancer, it should take some years of careful follow-up for that fact to become apparent, much less achieve statistical significance. We conclude that: roentgenographic and cytologic screening can detect cases at an earlier stage of the disease; those patients surgically resected in stage I (AJC) experience better survival, screening has not yet been shown to reduce mortality from lung cancer, but further judgment of its effectiveness awaits completion of three major studies reviewed in this report.",
author = "Williams, {D. E.} and Denis Cortese",
year = "1982",
language = "English (US)",
volume = "3",
pages = "210--217",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - The present status of screening and diagnosis of early lung cancer

AU - Williams, D. E.

AU - Cortese, Denis

PY - 1982

Y1 - 1982

N2 - The 'bottom line' regarding any benefit from detection and treatment of early lung cancer will be a difference in mortality in the screened versus control groups. This has not yet been shown in the preliminary results of the cooperative studies - nor could we really expect it. If screening is indeed saving the lives of patients with early stage lung cancer, it should take some years of careful follow-up for that fact to become apparent, much less achieve statistical significance. We conclude that: roentgenographic and cytologic screening can detect cases at an earlier stage of the disease; those patients surgically resected in stage I (AJC) experience better survival, screening has not yet been shown to reduce mortality from lung cancer, but further judgment of its effectiveness awaits completion of three major studies reviewed in this report.

AB - The 'bottom line' regarding any benefit from detection and treatment of early lung cancer will be a difference in mortality in the screened versus control groups. This has not yet been shown in the preliminary results of the cooperative studies - nor could we really expect it. If screening is indeed saving the lives of patients with early stage lung cancer, it should take some years of careful follow-up for that fact to become apparent, much less achieve statistical significance. We conclude that: roentgenographic and cytologic screening can detect cases at an earlier stage of the disease; those patients surgically resected in stage I (AJC) experience better survival, screening has not yet been shown to reduce mortality from lung cancer, but further judgment of its effectiveness awaits completion of three major studies reviewed in this report.

UR - http://www.scopus.com/inward/record.url?scp=0020378785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020378785&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0020378785

VL - 3

SP - 210

EP - 217

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 3

ER -